SAVE THE DATE: Eagle Pharmaceuticals to Host Investor Day on Tuesday, December 6, 2022, at the Lotte New York Palace Hotel
globenewswire.com
news
2022-10-19 21:00:00

WOODCLIFF LAKE, N.J., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or the 'Company') today announced that the Company will host an Investor Day on Tuesday, December 6, 2022, at the Lotte New York Palace Hotel, at 8:00am ET. The program will provide an opportunity for an in-depth look at the Company's hospital-based products, including CAL02, BARHEMSYS® and BYFAVO®, and Enalare's ENA-001. Featured speakers include Scott Tarriff, President and Chief Executive Officer, senior members of Eagle's clinical and commercial teams, and noteworthy Key Opinion Leaders, who will discuss the scientific rationale and potential unmet medical needs for each pipeline asset and commercial product.
